Filtros : "Life Sciences" "2009" Removido: "FARMACOLOGIA" Limpar

Filtros



Refine with date range


  • Source: Life Sciences. Unidade: FFCLRP

    Subjects: MOVIMENTAÇÃO DENTÁRIA, OSTEOCLASTO, LIPOSSOMOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ALVES, José B. et al. Local delivery of EGF-liposome mediated bone modeling in orthodontic tooth movement by increasing RANKL expression. Life Sciences, v. 85, n. 19-20, p. 693-699, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2009.09.010. Acesso em: 18 out. 2024.
    • APA

      Alves, J. B., Ferreira, C. L., Martins, A. F., Silva, G. A. B., Alves, G. D., Paulino, T. P., et al. (2009). Local delivery of EGF-liposome mediated bone modeling in orthodontic tooth movement by increasing RANKL expression. Life Sciences, 85( 19-20), 693-699. doi:10.1016/j.lfs.2009.09.010
    • NLM

      Alves JB, Ferreira CL, Martins AF, Silva GAB, Alves GD, Paulino TP, Ciancaglini P, Thedei Jr. G, Napimoga MH. Local delivery of EGF-liposome mediated bone modeling in orthodontic tooth movement by increasing RANKL expression [Internet]. Life Sciences. 2009 ; 85( 19-20): 693-699.[citado 2024 out. 18 ] Available from: https://doi.org/10.1016/j.lfs.2009.09.010
    • Vancouver

      Alves JB, Ferreira CL, Martins AF, Silva GAB, Alves GD, Paulino TP, Ciancaglini P, Thedei Jr. G, Napimoga MH. Local delivery of EGF-liposome mediated bone modeling in orthodontic tooth movement by increasing RANKL expression [Internet]. Life Sciences. 2009 ; 85( 19-20): 693-699.[citado 2024 out. 18 ] Available from: https://doi.org/10.1016/j.lfs.2009.09.010
  • Source: Life Sciences. Unidade: FMRP

    Assunto: NEFROPATIAS (TRATAMENTO)

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FRANCESCATO, Heloísa Della Coletta et al. Treatment with a p38 MAPK inhibitor attenuates cisplatin nephrotoxicity starting after the beginning of renal damage. Life Sciences, v. 84, n. 17-18, p. 590-597, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2009.02.004. Acesso em: 18 out. 2024.
    • APA

      Francescato, H. D. C., Costa, R. S., Silva, C. G. A. da, & Coimbra, T. M. (2009). Treatment with a p38 MAPK inhibitor attenuates cisplatin nephrotoxicity starting after the beginning of renal damage. Life Sciences, 84( 17-18), 590-597. doi:10.1016/j.lfs.2009.02.004
    • NLM

      Francescato HDC, Costa RS, Silva CGA da, Coimbra TM. Treatment with a p38 MAPK inhibitor attenuates cisplatin nephrotoxicity starting after the beginning of renal damage [Internet]. Life Sciences. 2009 ; 84( 17-18): 590-597.[citado 2024 out. 18 ] Available from: https://doi.org/10.1016/j.lfs.2009.02.004
    • Vancouver

      Francescato HDC, Costa RS, Silva CGA da, Coimbra TM. Treatment with a p38 MAPK inhibitor attenuates cisplatin nephrotoxicity starting after the beginning of renal damage [Internet]. Life Sciences. 2009 ; 84( 17-18): 590-597.[citado 2024 out. 18 ] Available from: https://doi.org/10.1016/j.lfs.2009.02.004

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024